Survival outcomes of patients with end stage renal disease are worse than those of many
metastatic cancers. Kidney disease patients are often inflicted with higher rates of …

Recent advances in microbiome research have informed the potential role of the gut
microbiota in the regulation of metabolic, cardiovascular, and renal systems, and, when …

In chronic kidney disease (CKD), cardiovascular (CV) damage is present in parallel which
leads to an increased risk of CV disease. Both traditional and non-traditional risk factors …

Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …

Recent findings regarding the influence of the microbiota in many inflammatory processes
have provided a new way to treat diseases. Now, one may hypothesize that the origin of a …

Patients with chronic kidney disease (CKD) suffer from marked cardiovascular morbidity and
mortality, so lowering the cardiovascular risk is paramount to improve quality of life and …

With over 100 trillion microbial cells, the gut microbiome plays important roles in both the
maintenance of health and the pathogenesis of disease. Gut microbiome dysbiosis, resulted …

Diabetic kidney disease (DKD) represents a growing public health burden and is the leading
cause of end-stage kidney diseases. In recent years, host-gut microbiota interactions have …

The normal intestinal microbiota plays a major role in the maintenance of health and
disease prevention. In fact, the alteration of the intestinal microbiota has been shown to …

Large microbial communities reside in the gut as an endogenous organ and interact with the
host physiology through symbiotic relationships, affecting health. Recent advances in high …